# REIN THERAPEUTICS INC (RNTX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RNTX/

- Reporting holders: 60
- Reported value: $45.9M
- Shares held by institutions: 44,108,108 of 86,267,032 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Voss Capital, LP](https://holderbook.com/funds/1730145-voss-capital-lp/) | $5.5M | 5,261,921 | 0.3% | 7 |
| [Cable Car Capital, LP](https://holderbook.com/funds/1699575-cable-car-capital-lp/) | $5.4M | 5,195,000 | 0.1% | 9 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $5.1M | 4,877,422 | 0.0% | 1 |
| [ADAR1 Capital Management, LLC](https://holderbook.com/funds/1940272-adar1-capital-management-llc/) | $4.7M | 4,500,000 | 0.2% | 1 |
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $3.5M | 3,377,910 | 0.0% | 2 |
| [BIOS Capital Management, LP](https://holderbook.com/funds/1813845-bios-capital-management-lp/) | $3.1M | 2,982,375 | 7.4% | 7 |
| [Ikarian Capital, LLC](https://holderbook.com/funds/1778253-ikarian-capital-llc/) | $3.1M | 2,950,000 | 0.3% | 1 |
| [GREAT POINT PARTNERS LLC](https://holderbook.com/funds/1281446-great-point-partners-llc/) | $2.7M | 2,575,000 | 0.5% | 1 |
| [Velan Capital Investment Management LP](https://holderbook.com/funds/1848809-velan-capital-investment-management-lp/) | $1.8M | 1,700,000 | 1.1% | 1 |
| [Senvest Management, LLC](https://holderbook.com/funds/1328785-senvest-management-llc/) | $1.3M | 1,230,895 | 0.0% | 10 |
| [Prosight Management, LP](https://holderbook.com/funds/1617201-prosight-management-lp/) | $1.1M | 1,100,000 | 0.2% | 9 |
| [Bleichroeder LP](https://holderbook.com/funds/1781002-bleichroeder-lp/) | $1.0M | 1,000,000 | 0.2% | 1 |
| [BOOTHBAY FUND MANAGEMENT, LLC](https://holderbook.com/funds/1549230-boothbay-fund-management-llc/) | $925.0K | 889,450 | 0.0% | 1 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $789.6K | 759,208 | 0.0% | 9 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $762.5K | 733,139 | 0.0% | 15 |
| [UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO](https://holderbook.com/funds/1019231-university-of-texas-texas-am-investment-management-co/) | $532.1K | 511,610 | 0.1% | 9 |
| [Stonepine Capital Management, LLC](https://holderbook.com/funds/1440771-stonepine-capital-management-llc/) | $453.5K | 436,076 | 0.1% | 1 |
| [VANGUARD FIDUCIARY TRUST CO](https://holderbook.com/funds/933478-vanguard-fiduciary-trust-co/) | $397.8K | 382,515 | 0.0% | 2 |
| [Empery Asset Management, LP](https://holderbook.com/funds/1469336-empery-asset-management-lp/) | $385.7K | 370,834 | 0.4% | 1 |
| [Palogic Value Management, L.P.](https://holderbook.com/funds/1532943-palogic-value-management-l-p/) | $374.4K | 360,000 | 0.1% | 2 |
| [Sigma Planning Corp](https://holderbook.com/funds/1449126-sigma-planning-corp/) | $367.8K | 353,677 | 0.0% | 11 |
| [BlackRock, Inc.](https://holderbook.com/funds/2012383-blackrock-inc/) | $339.3K | 326,204 | 0.0% | 8 |
| [Texas Capital Bank Wealth Management Services Inc](https://holderbook.com/funds/1802655-texas-capital-bank-wealth-management-services-inc/) | $312.8K | 300,758 | 0.0% | 11 |
| [Sequoia Financial Advisors, LLC](https://holderbook.com/funds/1599900-sequoia-financial-advisors-llc/) | $260.0K | 250,000 | 0.0% | 1 |
| [GAGNON SECURITIES LLC](https://holderbook.com/funds/1125725-gagnon-securities-llc/) | $238.2K | 229,070 | 0.0% | 11 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 60 | $45.9M |
| Q1 2026 | 45 | $14.8M |
| Q4 2025 | 46 | $12.5M |
| Q3 2025 | 38 | $9.7M |
| Q2 2025 | 35 | $9.5M |
| Q1 2025 | 36 | $10.6M |
| Q4 2024 | 30 | $13.1M |
| Q3 2024 | 29 | $16.3M |
| Q2 2024 | 27 | $14.8M |
| Q1 2024 | 22 | $11.0M |
| Q4 2023 | 19 | $3.2M |
| Q3 2023 | 15 | $1.6M |